✉ Email this page to a colleague
« Back to Dashboard
Imipramine Pamoate is a drug marketed by Hikma, Lupin Ltd, and Rising. and is included in three NDAs.
The generic ingredient in IMIPRAMINE PAMOATE is imipramine pamoate. There are thirty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the imipramine pamoate profile page.
A generic version of IMIPRAMINE PAMOATE was approved as imipramine pamoate by HIKMA on April 16th, 2010.
Summary for IMIPRAMINE PAMOATE
|Finished Product Suppliers / Packagers:||2|
|Raw Ingredient (Bulk) Api Vendors:||8|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for IMIPRAMINE PAMOATE|
|What excipients (inactive ingredients) are in IMIPRAMINE PAMOATE?||IMIPRAMINE PAMOATE excipients list|
|DailyMed Link:||IMIPRAMINE PAMOATE at DailyMed|
Recent Clinical Trials for IMIPRAMINE PAMOATE
Identify potential brand extensions & 505(b)(2) entrants
|Shalvata Mental Health Center||N/A|
Pharmacology for IMIPRAMINE PAMOATE
|Drug Class||Tricyclic Antidepressant |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Hikma||IMIPRAMINE PAMOATE||imipramine pamoate||CAPSULE;ORAL||091099-001||Apr 16, 2010||AB||RX||No||Yes||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Lupin Ltd||IMIPRAMINE PAMOATE||imipramine pamoate||CAPSULE;ORAL||090444-003||Apr 16, 2010||AB||RX||No||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|Hikma||IMIPRAMINE PAMOATE||imipramine pamoate||CAPSULE;ORAL||091099-004||Apr 16, 2010||AB||RX||No||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|